{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-267364","form_type":"8-K","ticker":"NERV","cik":"0001598646","company_name":"Minerva Neurosciences, Inc.","filed_at":"2021-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.744703+00:00","generated_at":"2026-06-29T05:12:25.510408+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Minerva Neurosciences appoints Dr. Kuchibhatla as SVP Head of R&D; Dr. Saoud to advisory role","bullets":["Dr. Jay Saoud resigns as SVP Head of R&D effective Sept 15, 2021; transitions to consultant through June 2022.","Dr. Ramana Kuchibhatla appointed as Senior VP & Head of R&D effective Sept 16, 2021, reporting to CEO.","Saoud will continue supporting preparation and submission of NDA for roluperidone (negative symptoms of schizophrenia).","Consulting fee: $412.50/hr first 20 hrs/wk, $500/hr beyond; equity awards accelerate upon completion or early termination.","Kuchibhatla has over 35 years drug development experience from PRA Health Sciences, Melior, Targacept, GSK."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-267364","json":"https://secwatch.observer/filing/0001193125-21-267364.json","markdown":"https://secwatch.observer/filing/0001193125-21-267364.md","text":"https://secwatch.observer/filing/0001193125-21-267364.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1598646/000119312521267364/0001193125-21-267364-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1598646/000119312521267364/d196078d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T05:12:25.510408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}